Sleepwalking [somnambulism]

F5_SLEEPWALKING

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51.3 Cause of death: ICD-10 — F51.3 2 out of 7 registries used, show all original rules.	129
4. Check minimum number of events None	129
5. Include endpoints None	129
6. Filter based on genotype QC (FinnGen only)	118

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_SLEEPWALKING
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F513
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F513
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleepwalking [somnambulism] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	741	345	395
Only index persons	706	334	372
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	24.02	29.30	19.39
Only index persons	24.31	29.66	19.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	118	87	31
Unadjusted period prevalence (%)	0.03	0.03	0.01
Median age at first event (years)	33.40	35.04	28.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
122: Matched controls
1220

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

+∞

174.0

122

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

171.5

26.8

G47.9

ICD-10 Finland

Sleep disorder, unspecified

20.2

21.2

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

98.0

16.0

N03AE01

ATC

clonazepam; systemic

14.0

14.6

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

9.7

10.0

N05AH04

ATC

quetiapine; oral

3.5

9.8

178

F51.0

ICD-10 Finland

Nonorganic insomnia

3.3

9.2

211

N05AX08

ATC

risperidone; systemic

5.1

8.7

N06AX11

ATC

mirtazapine; oral

3.1

8.7

305

N03AX12

ATC

[U] gabapentin; oral

4.0

8.4

N06AX16

ATC

venlafaxine; oral

3.6

7.9

111

H02AB07

ATC

prednisone; oral

4.1

7.9

F51.5

ICD-10 Finland

Nightmares

48.1

7.8

G47.3

ICD-10 Finland

Sleep apnoea

3.4

7.8

124

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

6.8

7.8

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

85.0

7.5

N05AA02

ATC

levomepromazine; systemic

12.0

7.5

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.4

7.4

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.0

7.4

N05BA04

ATC

oxazepam; oral

2.9

7.1

224

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.3

6.9

120

N05AH03

ATC

olanzapine; systemic

4.1

6.6

H02AB06

ATC

prednisolone; systemic

2.7

6.6

366

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.1

6.5

P06

ICPC

Sleep disturbance

3.1

6.2

121

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.6

6.1

263

N06AX26

ATC

vortioxetine; oral

3.8

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

178

3.67

10.45

2.0

1.6

1.46

1.38

0.66

162

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

379

3.42

10.07

2.2

1.9

94.40

97.56

pmol/l

0.24

207

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

457

2.66

6.41

3.0

2.7

71.51

71.66

nmol/l

0.02

425

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3.54

6.34

1.8

1.5

0.12

0.36

mg/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

9.36

6.22

1.3

1.1

—

(42870588) Differential panel, method unspecified - Blood

334

2.57

6.10

5.7

7.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

356

2.43

5.45

3.8

3.2

23.87

28.51

u/l

1.70

334

(3000492) Spirometry study

122

2.68

4.53

1.4

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

390

2.13

4.05

10.3

8.2

1.22

mmol/l

0.07

336

(40758558) Short blood count panel - Blood

296

2.17

4.05

7.8

5.8

—

(3018418) pH of Serum or Plasma

244

2.18

3.84

3.9

3.7

7.40

7.39

0.24

173

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

4.47

3.82

1.1

—

(3025941) Bacteria identified in Stool by Culture

3.02

3.77

1.3

1.2

—

(3013115) Eosinophils [#/volume] in Blood

567

2.12

3.77

7.9

6.9

0.17

0.19

e9/l

0.49

503

(3000494) Fungus identified in Specimen by Culture

113

2.52

3.73

1.2

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

4.32

3.71

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

2.64

3.67

3.1

2.0

—

(3001604) Monocytes [#/volume] in Blood

542

2.07

3.63

8.0

6.6

0.50

0.54

e9/l

0.87

475

(3006315) Basophils [#/volume] in Blood

542

2.07

3.63

7.9

6.6

0.04

e9/l

0.39

473

(42529406) Shigella sp [Presence] in Stool by Culture

4.18

3.60

1.1

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

102

821

2.48

3.50

4.8

4.4

14.24

14.48

pmol/l

0.67

766

(3019198) Lymphocytes [#/volume] in Blood

566

2.05

3.50

7.9

6.5

2.09

2.04

e9/l

0.15

509

(3019150) Specific gravity of Urine by Refractometry

253

2.08

3.45

4.1

2.8

1.02

kg/l

0.11

154

(3024666) Lithium [Moles/volume] in Serum or Plasma

8.93

3.30

12.5

11.0

0.66

0.61

mmol/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.97

3.29

1.5

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

107

2.42

3.22

1.7

1.6

—

(40768797) Stomach Pathology biopsy report

124

2.28

3.03

1.5

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

10.35

3.00

1.0

1.2

145.60

151.00

nmol/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

535

1.91

2.99

6.6

6.0

6.36

6.20

mmol/l

0.29

475

(40768804) Tissue Pathology biopsy report

414

1.88

2.95

1.8

1.9

—

(3023368) Bacteria identified in Blood by Culture

218

2.00

2.90

3.9

4.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

330

1.87

2.79

3.6

2.9

—

(3022145) Colonoscopy Study observation

108

2.27

2.73

1.4

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

2.85

2.72

3.9

8.9

4.27

7.01

mmol/l

2.40

(3016879) Cocaine [Presence] in Urine

123

2.18

2.69

1.7

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

607

1.86

2.66

11.4

9.0

3.52

4.07

e9/l

2.62

532

(3027008) Opiates [Presence] in Urine

131

2.14

2.65

1.6

1.5

—

(3028300) Cannabinoids [Presence] in Urine

131

2.14

2.65

1.8

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.25

2.64

1.8

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

309

1.85

2.63

1.5

1.4

2.17

2.16

g/l

0.02

188

(3021589) Normoblasts [#/volume] in Blood

491

1.81

2.62

9.6

9.8

0.00

e9/l

0.50

398

(3002582) Erythrocytes [#/volume] in Urine

319

1.83

2.58

3.5

2.9

12.22

85.01

e6/l

1.86

231

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

7.38

2.57

1.2

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

347

1.81

2.54

1.5

1.4

1.14

1.02

u/ml

0.12

(3018095) Leukocytes [#/volume] in Urine

384

1.79

2.50

4.4

3.7

20.38

29.79

e6/l

0.29

246

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

173

1.97

2.47

2.7

2.5

1.67

0.89

e6/l

0.79

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.51

2.45

1.9

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

4.30

2.39

1.3

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

2.55

2.39

1.8

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

282

1.81

2.39

2.2

2.9

11.07

52.10

ng/l

1.04

141

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

106

914

2.22

2.35

4.8

3.6

5.71

5.60

mmol/l

0.46

100

855

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

3.65

2.31

1.3

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

612

1.76

2.30

4.4

3.2

67.93

68.71

ug/l

0.02

591

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

4.06

2.29

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

131

2.04

2.29

1.7

1.5

—

(3017732) Neutrophils [#/volume] in Blood

131

2.04

2.29

1.8

2.9

3.69

4.14

e9/l

0.53

122

(3026493) Urate [Moles/volume] in Serum or Plasma

202

1.87

2.27

2.8

277.38

316.60

umol/l

1.99

186

(3027944) Amphetamines [Presence] in Urine

132

2.02

2.24

1.7

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

116

1056

3.00

2.22

16.8

12.2

18.87

21.21

mg/l

0.40

829

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

164

1.92

2.19

2.6

5.45

3.31

e6/l

0.27

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

231

1.79

2.12

2.7

2.1

0.93

0.75

mg/l

0.22

166

(3032080) INR in Blood by Coagulation assay

309

1.72

2.10

2.6

7.9

1.01

1.10

inr

1.66

256

(3031040) Bacteria [#/volume] in Urine by Automated count

673

1.73

2.08

5.1

4.5

—

49.22

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

449

1.66

2.02

2.6

2.4

—

(3000991) Gas panel - Venous blood

2.30

1.97

19.1

9.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

108

957

2.12

1.91

14.3

10.5

97.97

96.14

ml/min/173m2

0.41

100

857

(3007853) Bacteria identified in Skin by Aerobe culture

109

2.00

1.91

2.7

1.5

—

(3015736) pH of Urine

474

1.63

1.88

4.0

3.0

6.38

6.27

0.25

260

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.40

1.87

4.2

4.9

24.49

24.40

mmol/l

0.06

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

118

1.94

1.85

4.0

2.8

3.24

7.53

umol/l

0.85

(3033658) Prothrombin time (PT) actual/Normal

240

1.71

1.84

10.5

4.1

96.28

94.60

0.19

235

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

4.29

1.84

1.0

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

184

1.76

1.75

2.4

2.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.03

1.75

1.4

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.01

1.71

11.6

8.9

105.35

104.59

mmol/l

0.33

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.56

1.69

1.6

5.5

0.65

0.61

—

(36304419) Bacteria [Presence] in Urine

281

1.63

1.66

3.5

2.6

—

estimate

—

(3030467) Casts [#/volume] in Urine by Automated count

282

1.62

1.64

3.5

2.8

0.28

0.14

e6/l

0.44

195

(3014051) Protein [Presence] in Urine by Test strip

327

1.60

1.63

2.8

3.0

—

0.00

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2.15

1.61

3.9

2.9

52.54

73.39

ng/l

0.81

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

103

913

1.82

1.61

3.7

3.3

1.09

1.21

mmol/l

1.17

868

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

156

1.76

1.60

2.0

3.3

7.67

28.99

ng/l

1.58

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

366

1.57

2.8

2.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

241

1.63

1.57

4.3

2.2

—

(3044290) Cell count panel - Cerebral spinal fluid

2.69

1.54

1.6

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.69

1.54

1.0

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.23

1.49

1.8

—

(3002032) Base excess in Venous blood by calculation

1.97

1.48

3.7

4.1

1.11

1.88

mmol/l

0.46

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

108

978

1.91

1.47

4.3

3.9

4.52

4.64

mmol/l

0.62

102

937

(3037522) Nuclear Ab [Titer] in Serum

161

1.70

1.43

1.4

1.5

432.00

492.90

titre

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

108

980

1.89

1.43

4.7

4.2

2.68

2.77

mmol/l

0.45

101

936

(3003458) Phosphate [Moles/volume] in Serum or Plasma

114

1.79

1.38

5.3

5.7

1.12

1.10

mmol/l

0.10

104

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.02

1.37

1.4

1.1

—

(3012516) Albumin [Mass/volume] in Urine

214

1.60

1.37

3.7

3.6

15.11

78.20

mg/l

1.47

143

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

107

972

1.82

1.35

4.2

3.8

1.47

1.46

mmol/l

0.15

101

929

(3012544) pH of Venous blood

1.90

1.34

3.7

4.5

7.39

—

(3009261) Glucose [Presence] in Urine by Test strip

579

1.49

1.34

4.7

3.5

0.00

estimate

-0.00

123

(3021601) Nitrite [Presence] in Urine by Test strip

570

1.48

1.32

4.5

3.4

0.00

estimate

-0.00

133

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

369

1.50

1.31

2.1

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.85

1.30

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.83

1.28

1.1

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.47

1.26

1.3

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2.47

1.26

1.0

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2.24

1.24

1.6

1.8

—

0.04

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

2.70

1.23

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

2.70

1.23

1.4

11.2

65.32

64.66

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.83

1.21

2.7

2.6

—

(36660697) Celiac disease serology panel - Serum

127

1.69

1.21

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

111

1.73

1.20

2.6

2.2

319.43

2553.62

u/l

—

(3020891) Body temperature

2.37

1.20

1.8

2.9

37.00

36.91

°c

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

104

949

1.65

1.14

19.6

15.0

13.36

13.23

0.54

104

941

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

341

1.45

1.13

2.7

2.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

215

1.52

1.12

4.0

4.2

6.07

10.60

mg/mmol

0.39

143

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

138

1.63

1.12

1.6

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.26

1.10

1.6

3.0

64.51

49.55

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.08

1.07

1.2

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.85

1.05

1.3

1.2

—

(1002224) Polysomnography panel

1.85

1.05

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.33

1.04

1.0

1.1

—

(3035350) Ketones [Presence] in Urine by Test strip

577

1.40

1.04

4.6

3.4

0.00

12.49

estimate

0.50

130

(3027945) Reticulocytes/Erythrocytes in Blood

1.80

1.03

1.8

3.6

1.53

1.89

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

100

1.69

1.03

1.6

—

(3022621) pH of Urine by Test strip

1.72

1.03

2.5

2.0

6.55

6.27

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

152

1.55

0.97

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

222

1.47

0.96

2.4

2.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

2.28

0.95

1.0

—

21.11

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.28

0.95

2.7

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

398

1.39

0.95

2.1

1.9

1.40

1.39

mmol/l

0.00

357

(3017143) Hepatitis C virus Ab [Presence] in Serum

223

1.46

0.94

1.5

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.69

0.92

1.5

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

225

1.44

0.90

1.4

1.3

20.40

29.23

iu/ml

—

(3002179) Metamyelocytes/Leukocytes in Blood

1.70

0.88

4.2

3.7

0.20

0.61

—

(3002256) Pathology report gross observation

123

1.54

0.83

1.1

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.73

0.82

2.2

1.3

—

(3042936) Bacteria identified in Isolate by Culture

124

1.53

0.81

2.8

2.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.71

0.80

1.8

1.7

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.79

0.0

4.2

—

54.46

—

(3044640) Blood type and Crossmatch panel - Blood

332

1.35

0.79

4.2

2.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.69

0.75

1.0

1.3

—

(3003694) ABO and Rh group [Type] in Blood

419

0.74

0.75

2.0

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

179

1.42

0.74

1.5

1.8

3.11

3.46

ratio

0.78

136

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

101

1.55

0.74

1.6

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1.79

0.72

1.1

1.5

—

13.31

—

(3050129) First trimester maternal screen panel - Serum or Plasma

128

0.60

0.68

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.54

0.67

1.4

28.80

20.56

iu/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

924

1.38

0.66

4.5

3.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.75

0.64

1.0

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

106

1.47

0.61

1.5

2.0

387.27

404.48

nmol/l

0.19

101

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.60

0.0

4.1

—

21.32

—

(3035715) Granulocytes [#/volume] in Blood

0.00

0.60

0.0

4.7

—

3.89

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.75

0.58

1.0

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.75

0.58

36.3

14.8

0.63

0.69

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.75

0.58

36.3

14.9

1.43

1.37

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

143

1.39

0.57

1.3

1.7

3.16

3.42

mmol/l

0.49

102

(3026008) Bacteria identified in Urine by Culture

300

1.28

0.56

2.6

2.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

329

1.27

0.55

1.9

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

302

1.27

0.53

5.1

3.3

0.00

estimate

-0.00

126

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.53

0.52

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

119

1.40

0.51

1.4

132.30

124.30

u/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.52

0.48

1.1

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

511

0.81

0.48

4.6

2.9

—

estimate

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

157

1.33

0.47

3.5

2.0

2.42

2.41

mmol/l

0.17

140

(40760892) CBC W Ordered Manual Differential panel - Blood

278

1.26

0.47

6.6

4.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.49

0.46

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

204

1.28

0.45

1.4

40.38

9.61

u/ml

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.64

0.43

1.0

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.54

0.42

1.4

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.41

0.0

1.5

—

20.60

—

(1616796) Gas panel - Central venous blood

0.00

0.41

0.0

2.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.5

—

18.90

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.41

0.0

2.8

—

4.96

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.41

0.0

2.8

—

9.38

—

(3012501) Base excess in Blood by calculation

0.00

0.41

0.0

2.8

—

2.44

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.41

0.0

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.49

0.41

1.0

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.49

0.41

1.4

2.4

—

(3019060) Gas panel - Arterial blood

1.41

0.38

1.8

16.9

—

(4024509) Urine culture

1.49

0.36

1.2

2.0

—

(40768443) Skin Pathology biopsy report

1.49

0.36

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.40

0.36

1.3

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.38

0.35

1.2

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.35

0.34

1.3

2.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.32

0.33

1.2

1.4

—

(3013512) EKG study

241

1.21

0.33

2.8

3.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

369

1.17

0.30

1.8

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.69

0.27

1.4

1.5

44.51

52.62

ug/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.5

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

1.4

—

9.29

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.21

0.0

1.9

—

0.97

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.21

0.0

2.2

—

92.53

—

(21494815) CD4 cells/Lymphocytes in Specimen

0.00

0.21

0.0

2.2

—

44.53

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.3

—

1.70

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

4.0

—

138.72

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.20

0.0

2.4

—

16.58

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

194

0.86

0.18

1.4

1.6

713.02

963.31

mu/l

0.67

166

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

264

1.13

0.17

1.5

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1.22

0.16

3.8

1.4

498.30

267.74

mu/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.74

0.16

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.81

0.15

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.81

0.15

1.3

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.78

0.15

1.4

1.6

—

(1761868) Lipid panel - Serum or Plasma

465

0.92

0.14

2.3

2.5

—

(21494755) Public health laboratory ask at order entry panel

145

0.88

0.10

1.0

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.08

0.09

51.3

11.0

26.33

25.04

mmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

432

1.07

0.09

4.7

3.0

0.00

0.01

estimate

0.50

118

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1.10

0.08

1.1

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.07

0.07

5.8

4.8

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.12

0.06

2.6

1.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

111

0.89

0.06

1.5

1.6

85.72

63.29

ug/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

149

1.08

0.05

2.4

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

262

1.04

0.02

1.8

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

348

0.97

0.02

3.4

2.8

0.00

estimate

-0.00

111

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.03

0.00

1.3

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

0.94

0.00

1.8

4.1

4.54

4.75

pmol/l

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

11.67

—

(3006270) Folate [Moles/volume] in Blood

0.00

-0.00

0.0

1.6

—

486.40

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

2.7

—

89.32

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

16.81

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

3.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.3

—

5.71

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

3.1

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

-0.00

0.0

1.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

6.8

—

196.00

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3008898) HLA-B27 [Presence]

0.90

-0.00

1.6

1.1

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.2

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

0.92

-0.00

4.7

3.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.1

—

32.78

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

13.08

—

(4035726) Immunohistochemistry procedure

0.97

-0.00

1.7

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.9

—

1030.13

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.02

-0.00

1.2

1.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

2.0

—

1.95

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3010503) CD19 cells [#/volume] in Blood

0.00

-0.00

0.0

2.0

—

173.43

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.00

-0.00

0.0

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

54.44

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.7

—

799.43

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SLEEPWALKING and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SLEEPWALKING.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_SLEEPWALKING – Sleepwalking [somnambulism]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleepwalking [somnambulism]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints